Abstracts tagged "rheumatoid arthritis (RA) and surgery"

Abstract Number: 2453 • 2018 ACR/ARHP Annual Meeting
Staphylococcus Aureus Carriage Rates Are High in Rheumatoid Arthritis Patients on Biologics
Susan M. Goodman¹, Bo Shopsin², Allina A. Nocon¹, Andy O. Miller³, Michael W. Henry³, Sarah E. Grond¹, Elianna Kaplowitz¹, Thomas P. Sculco⁴, Linda A. Russell³, Laura T. Donlin⁵, Mark P. Figgie⁴ and Peter K. Sculco⁴, ¹Hospital for Special Surgery, New York, NY, ²Medicine and Microbiology, New York University School of Medicine, New York, NY, ³Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁴Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁵Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY
Background/Purpose: Patients with rheumatoid arthritis (RA) have a higher risk of surgical site infection than patients with osteoarthritis (OA). Disease modifying therapy is widely used…
Abstract Number: 2469 • 2018 ACR/ARHP Annual Meeting
Early Referral and Flare´s Control Prevent Orthopaedic and Hand Surgery Indication in a Dynamic Cohort of Hispanic Early Rheumatoid Arthritis Patients
Irazú Contreras-Yáñez¹, Guillermo Guaracha², Efrain Díaz-Borjón³, Martin Iglesias⁴ and Virginia Pascual-Ramos⁵, ¹Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ²Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ³Orthopedics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ⁴Plastic Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ⁵Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico, Mexico City, Mexico
Background/Purpose: Rheumatoid arthritis (RA) patients from Latin-America present distinctive characteristics when compared to Caucasians, that are known to impact patient´s outcomes. Despite early and more…
Abstract Number: 2389 • 2017 ACR/ARHP Annual Meeting
Joint Surgery in Rheumatoid Arthritis 1980-2013: A Population-Based Study to Identify Risk Factors and Time Trends in Incidence
Michael Richter¹, Cynthia S. Crowson², Eric L. Matteson³ and Ashima Makol³, ¹Internal Medicine, Mayo Clinic, Rochester, MN, ²Department of Medicine, Division of Rheumatology,Mayo Clinic, Rochester, MN, ³Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: Over the past two decades, the use of disease modifying anti-rheumatic drugs and treat-to-target strategies have dramatically improved the outcomes of patients with rheumatoid…
Abstract Number: 143 • 2015 ACR/ARHP Annual Meeting
Fiber Optic Intubation in Patients with Rheumatoid Arthritis Who Had a Surgical Procedure
Gurjot Basra¹, Marylou Cardenas-Turanzas², Tayab Andrabi³, Katy Elizabeth French³, Bobby Bellard³, William A Murphy Jr.⁴, Maria A. Lopez-Olivo⁵ and Maria E. Suarez-Almazor⁵, ¹Baylor College of Medicine, Houston, TX, ²Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, ³Anesthesiology, The University of Texas, MD Anderson Cancer Center, Houston, TX, ⁴Radiology, The University of Texas, MD Anderson Cancer Center, Houston, TX, ⁵General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
Background/Purpose: Fiber optic intubation is the preferred method of airway management during anesthetic procedures for patients with RA. The purpose of our study was to…
Abstract Number: 907 • 2015 ACR/ARHP Annual Meeting
The Natural History of an Inception Cohort of Patients with Inflammatory Polyarthritis Followed for 20 Years: Disease Activity, Disability and Surgery
James Gwinnutt¹, Deborah P.M. Symmons¹, Alex J Macgregor², Jacqueline Chipping², Tarnya Marshall² and Suzanne M. Verstappen¹, ¹ARC Epidemiology, Stopford Building, ARC Epidemiology Unit, the University of Manchester, Manchester, United Kingdom, ²Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom
Background/Purpose: There is little data on the 20 year outcome of patients with inflammatory polyarthritis (IP). Hence the aim of this study was to describe…
Abstract Number: 2152 • 2014 ACR/ARHP Annual Meeting
Frequency of Postoperative Deep Infection in Patients with Rheumatoid Arthritis
Masayuki Azukizawa and Hiromu Ito, Orthopaedic surgery, Kyoto University, Kyoto, Japan
Background/Purpose: Rheumatoid arthritis (RA) is known to be associated with an increased risk of serious infection. It has been discussed about the risk of the…
Abstract Number: 466 • 2014 ACR/ARHP Annual Meeting
Should Anti-Tnfa treatment of RA be Stopped before Orthopedic Surgery?
Charlotte Mabille¹, Adeline Ruyssen Witrand², Thomas Barnetche^3,4, Arnaud Constantin⁵ and Alain G. Cantagrel⁵, ¹Rheumatology Unit, hopital Purpan, Toulouse, France, ²Rheumatolgy, CHU Purpan - Hôpital Pierre-Paul Riquet, Toulouse, France, ³rheumatology, Rheumatology department, Bordeaux University Hospital, bordeaux, France, ⁴Rheumatology department, Bordeaux University Hospital, bordeaux, France, ⁵Rheumatology, CHU Purpan - Hôpital Pierre-Paul Riquet, Toulouse, France
Background/Purpose Anti-TNFs have greatly contributed to improve RA prognosis. Hence, the needs for orthopedic surgery have considerably decreased in the past years. However, surgery, whether…
Abstract Number: 1043 • 2013 ACR/ARHP Annual Meeting
Musculoskeletal Hospital Admissions Among Patients Treated For Rheumatoid Arthritis Between 1999 and 2010 Compared With The General Population In The Netherlands
I D Bezemer¹, L M A Houweling¹, E Alemao², F J A Penning-van Beest¹ and M Hochberg³, ¹PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands, ²Bristol-Myers Squibb, Princeton, NJ, ³University of Maryland, Baltimore, MD
Background/Purpose: Advances in treatment for RA may have resulted in a decrease in musculoskeletal hospital admissions. This study aimed to assess the trends in hospital…
Abstract Number: 807 • 2013 ACR/ARHP Annual Meeting
Perioperative Use Of Anti-Rheumatic Agents Does Not Increase Early Postoperative Infection Risks: A Veteran Affairs’ Administrative Database Study
Zaki AbouZahr¹, Andrew Spiegelman², Maria Cantu³ and Bernard Ng⁴, ¹Baylor College of Medicine, Houston, TX, ²Michael E DeBakey Veteran Affairs Medical Center, Houston, TX, ³Baylor College Of Medicine, Houston, TX, ⁴Michael E. DeBakey VA Medical Center, Houston, TX
Background/Purpose: Evidences for perioperative management of disease modifying anti-rheumatic drugs (DMARDs) and biologic agents (BA) are sparse, and limited mainly to methotrexate & specific surgeries…
Abstract Number: 204 • 2013 ACR/ARHP Annual Meeting
Evaluation Of Hospitalizations and Costs In Patients With Rheumatoid Arthritis In United States Medicare Population
E Alemao¹, L Wang², G Lltalien¹, O Baser³, H Yuce⁴ and M Hochberg⁵, ¹Bristol-Myers Squibb, Princeton, NJ, ²STATinMED Research, Dallas, TX, ³STATinMED Research and University of Michigan, Ann Arbor, MI, ⁴New York City College of Technology (CUNY), Brooklyn, NJ, ⁵University of Maryland, Baltimore, MD
Background/Purpose: RA-related hospitalization and surgery (e.g. total joint arthroplasty [TJA]) are important long-term outcomes in RA. While advances in treatment for RA have resulted in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].